Physician profile
Bernard E Rerri
NPI 1972587061
$4,715.14
in general payments reported to CMS, 2019-2025
19 companies · $181 in 2025
The $181 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $195 · 2020: $200 · 2021: $1,724 · 2022: $2,002 · 2023: $163 · 2024: $251 · 2025: $181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $594.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $593.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,363.80 | 2022 | |
| Elite Orthopedics, LLC | $1,213.73 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $591.07 | 2022-2025 | Relistor, Trulance |
| Stryker Corporation | $334.54 | 2020-2024 | T2 Alpha |
| Depuy Synthes Sales INC. | $321.94 | 2019-2022 | |
| Si-Bone, INC. | $311.22 | 2021-2023 | |
| Orthofix Medical, INC. | $138.64 | 2020-2024 | Physio-Stim |
| Alexion Pharmaceuticals, INC. | $116.24 | 2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $49.83 | 2022 | |
| Surgalign Spine Technologies, INC. | $48.49 | 2020 | |
| Zimvie INC. | $47.23 | 2022 | |
| Electronic Waveform Lab, INC. | $31.52 | 2021 | |
| Abbvie INC. | $29.61 | 2022 | |
| Abbott Laboratories | $28.75 | 2020 | |
| Ferring Pharmaceuticals INC. | $23.93 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $21.01 | 2022 | |
| Pacira Therapeutics, INC. | $18.50 | 2021 | |
| Baudax Bio INC. | $13.72 | 2020 | |
| Assertio Therapeutics, INC. | $11.37 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bernard Rerri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.